Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health. David’s research has also included the use of “food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes. You can follow David on ‘X’ at @godiabetesmd.Dr. Elissa R. Weitzman is Associate Professor of Pediatrics at Harvard Medical School, and of Adolescent/Young Adult Medicine at Boston Children's Hospital. Her research focuses on improving the health of youth, with an emphasis on addressing chronic illness and behavioral health problems. A mixed-methods scientist, Weitzman uses narrative, cohort, and “big data” passive or participatory surveillance methods to illuminate the epidemiology and experience of chronic illness. Recognizing population engagement with digital health tools and online disease communities, she has investigated willingness to share electronic data for research, quantified the quality and safety of online health communities, and tested informatics-enabled models for returning research data to cohorts to drive engagement. Weitzman has a Bachelor’s from Brandeis University, a Masters and Doctorate from the Harvard TH Chan School of Public Health, and has completed post-doctoral training in Medical Ethics and Public Health in Psychiatry at the Harvard Medical School.

Select Guide Rating

• Part I: Building digital health and telehealth tools for diabetes1. Democratizing access to and understanding of health information in the era of telehealthDavid Kerr and Namino Glantz2. Building digital health tools for diabetes: how user interface research and user experience design can improve digital health adoptionAmy Oughton3. Incorporating diabetes technology data into the EHRJuan Espinoza4. Interoperability risks and health informaticsAnura S. Fernando5. Cybersecurity in the diabetes care ecosystemAxel Wirth6. Privacy and diabetes digital technologies and telehealth servicesElissa R. Weitzman and Melanie Floyd7. Telehealth and digital health privacy regulationsRandi Seigel, Scott T. Lashway, Matthew M.K. Stein and C.J. Rundell8. Business considerations in starting a diabetes digital health companyDavid J. KimPart II: Diabetes digital health and telehealth for individuals9. Digital health apps for people with diabetesJoi Hester, Zohyra Zabala, Kate Winskell and Francisco J. Pasquel10. Telehealth for diabetes: a durable, evolving solutionMichelle L. Griffith and Leslie Eiland11. Digital health and telehealth for behavior change in diabetesMichelle L. Litchman, Julia E. Blanchette, Cherise Shockley and Tamara K. Oser12. Digital support for physical activitySheri R. Colberg and Gary Scheiner13. Psychosocial responses to telehealth for diabetes careShideh Majidi and Jennifer K. Raymond14. Remote blood pressure monitoringTrisha Shang, Jennifer Y. Zhang, Dessi P. Zaharieva and David C. Klonoff15. Digital health and telehealth for pregnancyMercedes Rigla Cros, M. Elena Hernando and Gema Garcı´a-Sa´ez16. Digital health technologies for patients in diabetes self-management education and supportShiyu Li and Jing WangPart III: Diabetes digital health and telehealth for populations17. Use of digital health and telehealth in the USDavid T. Ahn18. Diabetes digital health and telehealth in the Middle EastMohammed E. Al-Sofiani19. An Asian perspective on digital health for diabetesLauren Hartz and Kayo Waki20. Impact of digital technology on managing diabetes in the hospitalSara Donevant, Urooj Najmi, Umair Ansari, Waqas Haque and Mihail Zilbermint21. Disparities in digital health in underserved populationsCeleste Campos-Castillo and Lindsay S. Mayberry22. Telehealth for training diabetes professionalsSean M. Oser and Tamara K. Oser23. Outcomes assessment for digital health interventions in diabetes: a payer perspectiveJordan Silberman, Siavash Sarlati, Manpreet Kaur and Warris Bokhari

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health. David’s research has also included the use of “food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes. You can follow David on ‘X’ at @godiabetesmd.Dr. Elissa R. Weitzman is Associate Professor of Pediatrics at Harvard Medical School, and of Adolescent/Young Adult Medicine at Boston Children's Hospital. Her research focuses on improving the health of youth, with an emphasis on addressing chronic illness and behavioral health problems. A mixed-methods scientist, Weitzman uses narrative, cohort, and “big data” passive or participatory surveillance methods to illuminate the epidemiology and experience of chronic illness. Recognizing population engagement with digital health tools and online disease communities, she has investigated willingness to share electronic data for research, quantified the quality and safety of online health communities, and tested informatics-enabled models for returning research data to cohorts to drive engagement. Weitzman has a Bachelor’s from Brandeis University, a Masters and Doctorate from the Harvard TH Chan School of Public Health, and has completed post-doctoral training in Medical Ethics and Public Health in Psychiatry at the Harvard Medical School.

Select Guide Rating

• Part I: Building digital health and telehealth tools for diabetes1. Democratizing access to and understanding of health information in the era of telehealthDavid Kerr and Namino Glantz2. Building digital health tools for diabetes: how user interface research and user experience design can improve digital health adoptionAmy Oughton3. Incorporating diabetes technology data into the EHRJuan Espinoza4. Interoperability risks and health informaticsAnura S. Fernando5. Cybersecurity in the diabetes care ecosystemAxel Wirth6. Privacy and diabetes digital technologies and telehealth servicesElissa R. Weitzman and Melanie Floyd7. Telehealth and digital health privacy regulationsRandi Seigel, Scott T. Lashway, Matthew M.K. Stein and C.J. Rundell8. Business considerations in starting a diabetes digital health companyDavid J. KimPart II: Diabetes digital health and telehealth for individuals9. Digital health apps for people with diabetesJoi Hester, Zohyra Zabala, Kate Winskell and Francisco J. Pasquel10. Telehealth for diabetes: a durable, evolving solutionMichelle L. Griffith and Leslie Eiland11. Digital health and telehealth for behavior change in diabetesMichelle L. Litchman, Julia E. Blanchette, Cherise Shockley and Tamara K. Oser12. Digital support for physical activitySheri R. Colberg and Gary Scheiner13. Psychosocial responses to telehealth for diabetes careShideh Majidi and Jennifer K. Raymond14. Remote blood pressure monitoringTrisha Shang, Jennifer Y. Zhang, Dessi P. Zaharieva and David C. Klonoff15. Digital health and telehealth for pregnancyMercedes Rigla Cros, M. Elena Hernando and Gema Garcı´a-Sa´ez16. Digital health technologies for patients in diabetes self-management education and supportShiyu Li and Jing WangPart III: Diabetes digital health and telehealth for populations17. Use of digital health and telehealth in the USDavid T. Ahn18. Diabetes digital health and telehealth in the Middle EastMohammed E. Al-Sofiani19. An Asian perspective on digital health for diabetesLauren Hartz and Kayo Waki20. Impact of digital technology on managing diabetes in the hospitalSara Donevant, Urooj Najmi, Umair Ansari, Waqas Haque and Mihail Zilbermint21. Disparities in digital health in underserved populationsCeleste Campos-Castillo and Lindsay S. Mayberry22. Telehealth for training diabetes professionalsSean M. Oser and Tamara K. Oser23. Outcomes assessment for digital health interventions in diabetes: a payer perspectiveJordan Silberman, Siavash Sarlati, Manpreet Kaur and Warris Bokhari

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health. David’s research has also included the use of “food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes. You can follow David on ‘X’ at @godiabetesmd.Dr. Elissa R. Weitzman is Associate Professor of Pediatrics at Harvard Medical School, and of Adolescent/Young Adult Medicine at Boston Children's Hospital. Her research focuses on improving the health of youth, with an emphasis on addressing chronic illness and behavioral health problems. A mixed-methods scientist, Weitzman uses narrative, cohort, and “big data” passive or participatory surveillance methods to illuminate the epidemiology and experience of chronic illness. Recognizing population engagement with digital health tools and online disease communities, she has investigated willingness to share electronic data for research, quantified the quality and safety of online health communities, and tested informatics-enabled models for returning research data to cohorts to drive engagement. Weitzman has a Bachelor’s from Brandeis University, a Masters and Doctorate from the Harvard TH Chan School of Public Health, and has completed post-doctoral training in Medical Ethics and Public Health in Psychiatry at the Harvard Medical School.

Select Guide Rating

• Part I: Building digital health and telehealth tools for diabetes1. Democratizing access to and understanding of health information in the era of telehealthDavid Kerr and Namino Glantz2. Building digital health tools for diabetes: how user interface research and user experience design can improve digital health adoptionAmy Oughton3. Incorporating diabetes technology data into the EHRJuan Espinoza4. Interoperability risks and health informaticsAnura S. Fernando5. Cybersecurity in the diabetes care ecosystemAxel Wirth6. Privacy and diabetes digital technologies and telehealth servicesElissa R. Weitzman and Melanie Floyd7. Telehealth and digital health privacy regulationsRandi Seigel, Scott T. Lashway, Matthew M.K. Stein and C.J. Rundell8. Business considerations in starting a diabetes digital health companyDavid J. KimPart II: Diabetes digital health and telehealth for individuals9. Digital health apps for people with diabetesJoi Hester, Zohyra Zabala, Kate Winskell and Francisco J. Pasquel10. Telehealth for diabetes: a durable, evolving solutionMichelle L. Griffith and Leslie Eiland11. Digital health and telehealth for behavior change in diabetesMichelle L. Litchman, Julia E. Blanchette, Cherise Shockley and Tamara K. Oser12. Digital support for physical activitySheri R. Colberg and Gary Scheiner13. Psychosocial responses to telehealth for diabetes careShideh Majidi and Jennifer K. Raymond14. Remote blood pressure monitoringTrisha Shang, Jennifer Y. Zhang, Dessi P. Zaharieva and David C. Klonoff15. Digital health and telehealth for pregnancyMercedes Rigla Cros, M. Elena Hernando and Gema Garcı´a-Sa´ez16. Digital health technologies for patients in diabetes self-management education and supportShiyu Li and Jing WangPart III: Diabetes digital health and telehealth for populations17. Use of digital health and telehealth in the USDavid T. Ahn18. Diabetes digital health and telehealth in the Middle EastMohammed E. Al-Sofiani19. An Asian perspective on digital health for diabetesLauren Hartz and Kayo Waki20. Impact of digital technology on managing diabetes in the hospitalSara Donevant, Urooj Najmi, Umair Ansari, Waqas Haque and Mihail Zilbermint21. Disparities in digital health in underserved populationsCeleste Campos-Castillo and Lindsay S. Mayberry22. Telehealth for training diabetes professionalsSean M. Oser and Tamara K. Oser23. Outcomes assessment for digital health interventions in diabetes: a payer perspectiveJordan Silberman, Siavash Sarlati, Manpreet Kaur and Warris Bokhari